Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aevi Genomic Medicine Inc (NASDAQ:GNMX)

1.33
Delayed Data
As of 4:00pm ET
 +0.01 / +0.76%
Today’s Change
0.98
Today|||52-Week Range
6.89
-74.32%
Year-to-Date
No recent news for Aevi Genomic Medicine Inc.

Today’s Trading

Previous close1.32
Today’s open1.28
Day’s range1.28 - 1.37
Volume133,786
Average volume (3 months)375,212
Market cap$49.0M
Dividend yield--
Data as of 4:00pm ET, 08/17/2017

Growth & Valuation

Earnings growth (last year)+17.93%
Earnings growth (this year)+19.12%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.40

Competitors

 Today’s
change
Today’s
% change
AGLEAeglea Bio Therapeut...-0.05-1.69%
ATNMActinium Pharmaceuti...0.000.00%
XENEXenon Pharmaceutical...+0.15+5.66%
JNPJuniper Pharmaceutic...+0.10+2.27%
Data as of 7:59pm ET, 08/17/2017

Financials

Last reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$0.00
Annual profit (last year)-$41.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael F. Cola
Secretary, Chief Financial &
Accounting Officer
Brian D. Piper
Corporate headquarters
Wayne, Pennsylvania

Forecasts